These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12001341)

  • 1. The effect of administering long-acting oxytetracycline and tilmicosin either by dart gun or by hand on injection site lesions and drug residues in beef cattle.
    Van Donkersgoed J; VanderKop M; Salisbury C; Sears L; Holowath J
    Can Vet J; 1999 Aug; 40(8):583-7. PubMed ID: 12001341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residue depletion of tilmicosin in cattle after subcutaneous administration.
    Jiang H; Ding S; Li J; An D; Li C; Shen J
    J Agric Food Chem; 2006 Jul; 54(14):5208-13. PubMed ID: 16819937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting antibiotic formulations in the treatment of calf pneumonia: a comparative study of tilmicosin and oxytetracycline.
    Laven R; Andrews AH
    Vet Rec; 1991 Aug; 129(6):109-11. PubMed ID: 1926728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of two long-acting oxytetracycline products administered subcutaneously and intramuscularly.
    Clarke CR; Wang Z; Cudd L; Burrows GE; Kirkpatrick JG; Brown MD
    J Vet Pharmacol Ther; 1999 Feb; 22(1):65-7. PubMed ID: 10211720
    [No Abstract]   [Full Text] [Related]  

  • 5. Tilmicosin antibacterial activity and pharmacokinetics in cows.
    Ziv G; Shem-Tov M; Glickman A; Winkler M; Saran A
    J Vet Pharmacol Ther; 1995 Oct; 18(5):340-5. PubMed ID: 8587151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of prophylactic efficacy of tilmicosin and a new formulation of oxytetracycline in feedlot calves.
    Schunich OC; Guichon PT; Booker CW; Jim GK; Wildman BK; Hill BW; Ward TI; Bauck SW; Jacobsen JA
    Can Vet J; 2002 May; 43(5):355-62. PubMed ID: 12001501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary investigation of the disposition of tilmicosin residues in elk tissues and serum.
    Clark C; Woodbury M; Dowling P; Ross S; Boison JO
    J Vet Pharmacol Ther; 2004 Oct; 27(5):385-7. PubMed ID: 15500580
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylactic efficacy of tilmicosin for bovine respiratory tract disease.
    Morck DW; Merrill JK; Thorlakson BE; Olson ME; Tonkinson LV; Costerton JW
    J Am Vet Med Assoc; 1993 Jan; 202(2):273-7. PubMed ID: 8428833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of tilmicosin in beef cattle following intravenous and subcutaneous administration.
    Lombardi KR; Portillo T; Hassfurther R; Hunter RP
    J Vet Pharmacol Ther; 2011 Dec; 34(6):583-7. PubMed ID: 21323676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Milk and blood pharmacokinetics of tylosin and tilmicosin following parenteral administrations to cows.
    Avci T; Elmas M
    ScientificWorldJournal; 2014; 2014():869096. PubMed ID: 25177733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tilmicosin administration to young lambs with respiratory infection: safety and efficacy considerations.
    Christodoulopoulos G; Warnick LD; Papaioannou N; Fthenakis GC
    J Vet Pharmacol Ther; 2002 Oct; 25(5):393-7. PubMed ID: 12423233
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum pharmacokinetics and tissue and milk residues of oxytetracycline in goats following a single intramuscular injection of a long-acting preparation and milk residues following a single subcutaneous injection.
    Payne MA; Babish JG; Bulgin M; Lane M; Wetzlich S; Craigmill AL
    J Vet Pharmacol Ther; 2002 Feb; 25(1):25-32. PubMed ID: 11874523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of plasma and lung concentrations after ceftiofur sodium and tilmicosin phosphate administered subcutaneously to mice.
    Brown SA; Deleeuw NR; Stahl GL; Roof RD
    J Vet Pharmacol Ther; 1995 Oct; 18(5):385-7. PubMed ID: 8587160
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of tilmicosin and cephapirin as therapeutics for Staphylococcus aureus mastitis at dry-off.
    Nickerson SC; Owens WE; Fox LK; Scheifinger CC; Shryock TR; Spike TE
    J Dairy Sci; 1999 Apr; 82(4):696-703. PubMed ID: 10212455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in residue concentrations of tilmicosin in cattle muscle.
    Beechinor JG; Bloomfield FJ
    Vet Rec; 2001 Aug; 149(6):182-3. PubMed ID: 11530904
    [No Abstract]   [Full Text] [Related]  

  • 16. Residues from long-acting antimicrobial preparations in injection sites in cattle.
    Mawhinney H; Oakenfull SM; Nicholls TJ
    Aust Vet J; 1996 Aug; 74(2):140-2. PubMed ID: 8894021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of tilmicosin with long-acting oxytetracycline for treatment of respiratory tract disease in calves.
    Musser J; Mechor GD; Gröhn YT; Dubovi EJ; Shin S
    J Am Vet Med Assoc; 1996 Jan; 208(1):102-6. PubMed ID: 8682696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of tilmicosin in sheep and cattle.
    Modric S; Webb AI; Derendorf H
    J Vet Pharmacol Ther; 1998 Dec; 21(6):444-52. PubMed ID: 9885967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmatory method for macrolide residues in bovine tissues by micro-liquid chromatography-tandem mass spectrometry.
    Draisci R; Palleschi L; Ferretti E; Achene L; Cecilia A
    J Chromatogr A; 2001 Aug; 926(1):97-104. PubMed ID: 11554423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of respiratory tract disease on pharmacokinetics of tilmicosin in rats.
    Modric S; Webb AI; Davidson M
    Lab Anim Sci; 1999 Jun; 49(3):248-53. PubMed ID: 10403438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.